The 9,600 Missed Diagnoses: How Geography Still Shapes Breast Cancer Outcomes
Despite improvements over the past few decades in breast cancer detection and care, an important new report says that 9,600 early-stage detections are being missed annually in the U.S.
Ten years ago, the results of this new Milken Institute report would have been unsurprising. But after a decade of attention, resources, and federal funding and policy focused on that breast cancer, there are still barriers to adoption. And it’s not what you might think.
The report - which is well worth a read over the weekend - emphasizes that population density, and ultimately, your zip code, are still determinants of healthcare access and outcomes. The study used the location of mammography machines in the U.S. to help predict areas that could use greater focus to ensure greater early detection of breast cancer.
First, some context:
Breast cancer is one of the leading causes of death in the U.S., expected to impact 42,000 women per year. In the past few decades, significant work has been done to ensure earlier detection. The Affordable Care Act helped by making it a covered preventative care service for women over the age of 40 – requiring private insurers and Medicare to cover the costs.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
AMA with Doximity CEO Jeff Tangney
Join Doximity CEO Jeff Tangney for a live Q&A on where clinicians are finding value with AI, how Doximity has evolved, and building a company from zero to IPO.
Office Hours
A live Q&A with Christina Farr and Ruth Reader, exclusively for Second Opinion Premium members. Thursday, November 19, 1:30–2:30 p.m. ET / 10:30–11:30 a.m. PT.
The Shift Left & the Impact of the Midterms on Healthcare
Democrats just took both chambers. Aneesh Chopra, Christopher Kerns and Mike Desjadon join Ruth Reader and Christina Farr live to talk through what they'll try to do on healthcare — and what's actually achievable under a Republican White House.
Is It Finally the Moment for Alternative Health Plans?
Register Here Employers are under growing pressure to control healthcare costs while improving access, outcomes, and the member experience. That has renewed
Type 2 Diabetes & Cardiometabolic Care: Wearables, AI & GLP-1s
Register Here The rise of wearables, GLP-1s, and AI is reshaping treatment for Type 2 diabetes, weight loss, and metabolic disease.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&